First Trust/Aberdeen Emerging Opportunity Fund (FEO), Eaton Vance Tax (ETY), MFS High Income Municipal Trust (CXE) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | First Trust/Aberdeen Emerging Opportunity Fund (FEO) | 15.31 | 0% | 9.14% | 2021-07-04 04:07:05 |
| 2 | Eaton Vance Tax (ETY) | 14.13 | 0.14% | 7.16% | 2021-07-04 03:24:04 |
| 3 | MFS High Income Municipal Trust (CXE) | 5.33 | 0.57% | 4.66% | 2021-07-04 00:14:22 |
| 4 | CVS Health Corp (CVS) | 82.43 | 0.26% | 2.39% | 2021-07-02 15:36:57 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. First Trust/Aberdeen Emerging Opportunity Fund (FEO) - Dividend Yield: 9.14%
First Trust/Aberdeen Emerging Opportunity Fund is a closed-ended balanced mutual fund launched and managed by First Trust Advisors L.P. It is co-managed by Aberdeen Asset Management Inc. The fund invests in public equity and fixed income markets of global emerging countries. It seeks to invest in the stocks of companies operating across the diversified sectors. For its fixed income component, the fund invests in government debt securities, corporate bonds, non investment-grade securities, asset-backed securities, credit-linked notes, and credit default swaps. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the Barclays Capital Global Emerging Markets Index, FTSE All World Emerging Market Index, and a blended index composed of JPMorgan Emerging Markets Bond Index - Global Diversified (32.5%); JPMorgan Government Bond Index - Emerging Markets (32.5%); MSCI Global Emerging Markets Index (35.0%). First Trust/Aberdeen Emerging Opportunity Fund was formed on August 28, 2006 and is domiciled in the United States.
Volume
Today's last reported volume for First Trust/Aberdeen Emerging Opportunity Fund is 20852, 39.81% above its average volume of 14915.
First Trust/Aberdeen Emerging Opportunity Fund's last close was $15.16, 4.53% below its 52-week high of $15.88.
First Trust/Aberdeen Emerging Opportunity Fund's Revenue
Year-on-year quarterly revenue growth declined by 37.9%, now sitting on 3.41M for the twelve trailing months.
First Trust/Aberdeen Emerging Opportunity Fund's Stock Yearly Top and Bottom Value
First Trust/Aberdeen Emerging Opportunity Fund's stock is valued at $15.31 at 10:15 EST, under its 52-week high of $15.88 and way higher than its 52-week low of $11.86.
First Trust/Aberdeen Emerging Opportunity Fund's Moving Average
First Trust/Aberdeen Emerging Opportunity Fund's value is under its 50-day moving average of $15.38 and above its 200-day moving average of $14.87.More news about First Trust/Aberdeen Emerging Opportunity Fund.
2. Eaton Vance Tax (ETY) - Dividend Yield: 7.16%
Eaton Vance Tax-Managed Diversified Equity Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in dividend paying stocks of companies. It also writes S&P 500 Index call options with respect to a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. The Fund also normally invests in issuers located in at least three countries including the United States. It also invests through derivatives. The fund benchmarks the performance of its portfolio against a composite benchmark comprised of 80% S&P 500 Index and 20% FTSE Eurotop 100 Index. Eaton Vance Tax-Managed Diversified Equity Income Fund was formed on November 30, 2006 and is domiciled in the United States.
Volume
Today's last reported volume for Eaton Vance Tax is 134446, 54.14% below its average volume of 293167.
Eaton Vance Tax's last close was $13.77, 4.11% below its 52-week high of $14.36.
Eaton Vance Tax's Revenue
Year-on-year quarterly revenue growth declined by 14.5%, now sitting on 30.6M for the twelve trailing months.
Eaton Vance Tax's Stock Yearly Top and Bottom Value
Eaton Vance Tax's stock is valued at $14.13 at 10:15 EST, under its 52-week high of $14.36 and way higher than its 52-week low of $10.29.
Eaton Vance Tax's Moving Average
Eaton Vance Tax's value is above its 50-day moving average of $13.91 and higher than its 200-day moving average of $13.01.More news about Eaton Vance Tax.
3. MFS High Income Municipal Trust (CXE) - Dividend Yield: 4.66%
MFS High Income Municipal Trust is a close ended fixed income mutual fund launched and managed by Massachusetts Financial Services Company. The fund invests in the fixed income markets. It primarily invests in municipal bonds and local general obligations of various sectors, such as multifamily, hospitals, care retirement, and investor-owned utilities. The fund benchmarks the performance of its portfolio against Barclays Municipal Bond Index. It was formerly known as Colonial High Income Municipal Trust. MFS High Income Municipal Trust was formed on February 17, 1989 and is domiciled in United States.
Volume
Today's last reported volume for MFS High Income Municipal Trust is 50244, 8.89% below its average volume of 55144.
MFS High Income Municipal Trust's last close was $5.47, 1.08% below its 52-week high of $5.53.
MFS High Income Municipal Trust's Revenue
Year-on-year quarterly revenue growth declined by 13.3%, now sitting on 11.29M for the twelve trailing months.
MFS High Income Municipal Trust's Stock Yearly Top and Bottom Value
MFS High Income Municipal Trust's stock is valued at $5.33 at 10:15 EST, below its 52-week high of $5.53 and way above its 52-week low of $4.59.
MFS High Income Municipal Trust's Moving Average
MFS High Income Municipal Trust's value is below its 50-day moving average of $5.35 and higher than its 200-day moving average of $5.18.More news about MFS High Income Municipal Trust.
4. CVS Health Corp (CVS) - Dividend Yield: 2.39%
CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans (PDPs), Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. The company was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Volume
Today's last reported volume for CVS Health Corp is 5444810, 18.17% below its average volume of 6653720.
CVS Health Corp's last close was $82.22, 9.26% under its 52-week high of $90.61.
CVS Health Corp's Sales
CVS Health Corp's sales growth is 9.2% for the current quarter and 5.6% for the next. The company's growth estimates for the ongoing quarter is a negative 22% and positive 12% for the next.
CVS Health Corp's Revenue
Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 270.11B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,CVS Health Corp's stock is considered to be overbought (>=80).
CVS Health Corp's Stock Yearly Top and Bottom Value
CVS Health Corp's stock is valued at $82.43 at 10:15 EST, under its 52-week high of $90.61 and way above its 52-week low of $55.36.
CVS Health Corp's Moving Average
CVS Health Corp's value is under its 50-day moving average of $85.60 and higher than its 200-day moving average of $76.64.More news about CVS Health Corp.